If you’ve been on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro — or you’re considering starting one — you may have heard the term “Ozempic face.” It’s not a medical diagnosis, but it describes a real phenomenon that dermatologists and plastic surgeons are seeing with increasing frequency.
What Is “Ozempic Face”?
GLP-1 receptor agonists are remarkably effective at promoting weight loss. But the body doesn’t choose where it loses fat. When patients lose 30, 50, or 80 pounds rapidly, they lose fat everywhere — including the face.
The fat compartments that give the face its youthful structure — in the cheeks, temples, around the eyes, and along the jawline — can deflate significantly with major weight loss. The result is a face that looks hollow, gaunt, or prematurely aged, even as the body looks dramatically healthier.
Patients often describe it as “My body looks 10 years younger but my face looks 10 years older.”
Why Fillers Aren’t the Best Answer
The instinct for many patients is to replace the lost facial volume with dermal fillers. This can work as a short-term measure, but it has significant limitations when the volume loss is structural.
Fillers are temporary. They dissolve over 6 to 18 months and need to be repeated indefinitely. They sit on top of the existing anatomy rather than rebuilding it. And when used in large volumes to compensate for significant fat loss, they can create an unnatural, overfilled appearance.
The underlying problem isn’t that the face needs material added to the surface. It’s that the structural fat that supported the face from within is gone.
A Structural Solution
The most effective correction for significant facial volume loss is structural fat grafting — using the patient’s own purified fat to rebuild the depleted compartments from within. This restores the face’s internal architecture rather than masking the loss with surface filler.
When combined with a deep plane facelift — as in The Ascend Lift™ by Dr. Shim Ching — the approach addresses both the deflation caused by weight loss and any tissue descent that may have accompanied it. The Sculpt component of the Ascend Lift targets the six key facial zones most affected by volume loss: cheeks, temples, upper eyelids, lips, piriform area, and jawline.
Because the grafted fat is enriched with SVF stem cells, it also supports ongoing skin quality improvement — addressing the skin laxity that often accompanies rapid weight loss.
Timing Matters
If you’re currently on a GLP-1 medication and still losing weight, most surgeons recommend waiting until your weight has stabilized for at least 3 to 6 months before pursuing facial surgery. This ensures that the correction is calibrated to your final weight rather than a moving target.
That said, a consultation while you’re still in the weight loss phase can be valuable. It allows your surgeon to evaluate your facial anatomy, discuss your goals, and develop a plan that’s ready to execute once you’ve reached your target.
You Shouldn’t Have to Choose
The promise of GLP-1 medications is a healthier body. That shouldn’t come at the cost of an aged face. With the right surgical approach, you can have both — a body you feel great about and a face that matches.
Take the Next Step
If you’re considering facial rejuvenation and want to understand whether The Ascend Lift™ is right for your anatomy and goals, schedule a private consultation with Dr. Ching. There’s no commitment and no pressure — just an honest conversation about what’s possible for your face.
➤ Schedule your Ascend Lift™ consultation or call (808) 207-7345.